Open AccessP1172: DUVELISIB IN PATIENTS WITH RELAPSED/REFRACTORY PERIPHERAL T‐CELL LYMPHOMA FROM THE PHASE 2 PRIMO TRIAL: UPDATED EXPANSION PHASE ANALYSIS
Author(s) -
Zinzani P. L.,
Zain J.,
Mead M.,
Casulo C.,
Jacobsen E. D.,
Gritti G.,
PinterBrown L.,
Isutzu K.,
Cohan D.,
Daugherty M.,
Brammer J. E.,
MehtaShah N.,
Pro B.,
Horwitz S. M.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000847552.42271.7c
Subject(s) - medicine , peripheral t cell lymphoma , regimen , refractory (planetary science) , lymphoma , interim analysis , oncology , interim , phases of clinical research , gastroenterology , clinical trial , surgery , t cell , immunology , immune system , physics , archaeology , astrobiology , history